Jacob Grinfeld

1.8k total citations
19 papers, 365 citations indexed

About

Jacob Grinfeld is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jacob Grinfeld has authored 19 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Jacob Grinfeld's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (9 papers) and Kruppel-like factors research (9 papers). Jacob Grinfeld is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (9 papers) and Kruppel-like factors research (9 papers). Jacob Grinfeld collaborates with scholars based in United Kingdom, Australia and United States. Jacob Grinfeld's co-authors include Anthony R. Green, Jyoti Nangalia, Anna L. Godfrey, Thorsten Klampfl, Daniel Prins, Juan Li, Peter J. Campbell, Claire Harrison, David G. Kent and Mary Frances McMullin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Jacob Grinfeld

17 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Grinfeld United Kingdom 11 277 228 177 112 28 19 365
Yoshitaka Sunami Japan 10 307 1.1× 263 1.2× 246 1.4× 70 0.6× 39 1.4× 18 449
Yoko Edahiro Japan 11 472 1.7× 356 1.6× 299 1.7× 138 1.2× 38 1.4× 51 593
Sabrina Cordua Denmark 8 235 0.8× 187 0.8× 102 0.6× 88 0.8× 28 1.0× 15 304
Nabih Maslah France 11 298 1.1× 290 1.3× 217 1.2× 163 1.5× 61 2.2× 30 458
Susanna Akiki Qatar 9 141 0.5× 219 1.0× 167 0.9× 58 0.5× 37 1.3× 32 347
Yumi Hironaka Japan 10 327 1.2× 265 1.2× 240 1.4× 75 0.7× 24 0.9× 13 424
Dushyant Verma United States 10 289 1.0× 415 1.8× 102 0.6× 112 1.0× 51 1.8× 14 486
Ravin J. Garg United States 9 200 0.7× 217 1.0× 82 0.5× 82 0.7× 56 2.0× 11 367
R. Hehlmann Germany 8 194 0.7× 212 0.9× 83 0.5× 111 1.0× 31 1.1× 20 308
Kaddour Chabane France 10 126 0.5× 128 0.6× 86 0.5× 52 0.5× 25 0.9× 17 242

Countries citing papers authored by Jacob Grinfeld

Since Specialization
Citations

This map shows the geographic impact of Jacob Grinfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Grinfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Grinfeld more than expected).

Fields of papers citing papers by Jacob Grinfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Grinfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Grinfeld. The network helps show where Jacob Grinfeld may publish in the future.

Co-authorship network of co-authors of Jacob Grinfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Grinfeld. A scholar is included among the top collaborators of Jacob Grinfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Grinfeld. Jacob Grinfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Godfrey, Anna L., Andrew McGregor, Andrew J. Innes, et al.. (2025). Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline. British Journal of Haematology. 208(2). 471–485.
2.
Belmonte, Miriam, Nina Friesgaard Øbro, Juan Li, et al.. (2024). Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models. Experimental Hematology. 135. 104246–104246. 1 indexed citations
3.
4.
Grinfeld, Jacob. (2020). Prognostic models in the myeloproliferative neoplasms. Blood Reviews. 42. 100713–100713. 10 indexed citations
5.
Øbro, Nina Friesgaard, Jacob Grinfeld, Miriam Belmonte, et al.. (2020). Longitudinal Cytokine Profiling Identifies GRO‐α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia. HemaSphere. 4(3). e371–e371. 39 indexed citations
6.
Prins, Daniel, et al.. (2020). Mutant Calreticulin in the Myeloproliferative Neoplasms. HemaSphere. 4(1). e333–e333. 27 indexed citations
7.
Andersen, Christen Lykkegaard, Jacob Grinfeld, Hans Carl Hasselbalch, et al.. (2019). Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat. Experimental Hematology. 79. 26–34. 7 indexed citations
8.
Godfrey, Anna L., Peter J. Campbell, Cathy MacLean, et al.. (2018). Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. Journal of Clinical Oncology. 36(34). 3361–3369. 49 indexed citations
9.
Pagano, Francesca, Federico Comoglio, Jacob Grinfeld, et al.. (2018). MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling. Leukemia. 32(8). 1826–1830. 2 indexed citations
10.
11.
Li, Juan, Daniel Prins, Hyun Jung Park, et al.. (2017). Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage. Blood. 131(6). 649–661. 57 indexed citations
12.
Grinfeld, Jacob & Anna L. Godfrey. (2016). After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera. Blood Reviews. 31(3). 101–118. 11 indexed citations
13.
Grinfeld, Jacob, Jyoti Nangalia, & Anthony R. Green. (2016). Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms. Haematologica. 102(1). 7–17. 63 indexed citations
14.
Nangalia, Jyoti, Jacob Grinfeld, & Anthony R. Green. (2016). Pathogenesis of Myeloproliferative Disorders. Annual Review of Pathology Mechanisms of Disease. 11(1). 101–126. 25 indexed citations
15.
Alonso‐Domínguez, Juan Manuel, Jacob Grinfeld, Mary Alikian, et al.. (2014). PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase. American Journal of Hematology. 90(1). 20–26. 10 indexed citations
16.
Grinfeld, Jacob, et al.. (2013). The peripheral blood features of acute myeloid leukemia with inv(16)(p13.1q22). American Journal of Hematology. 88(11). 975–975. 3 indexed citations
17.
Grinfeld, Jacob, Gareth Gerrard, Mary Alikian, et al.. (2013). A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia. British Journal of Haematology. 163(5). 631–639. 31 indexed citations
18.
Alonso‐Domínguez, Juan Manuel, Jacob Grinfeld, Mary Alikian, et al.. (2012). PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients. Blood. 120(21). 875–875. 1 indexed citations
19.
Bournazos, Stylianos, Jacob Grinfeld, Karen M. Alexander, et al.. (2010). Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulmonary Medicine. 10(1). 51–51. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Sunami Breakdown of academic impact, for papers by Yoko Edahiro Breakdown of academic impact, for papers by Sabrina Cordua Breakdown of academic impact, for papers by Nabih Maslah Breakdown of academic impact, for papers by Susanna Akiki Breakdown of academic impact, for papers by Yumi Hironaka Breakdown of academic impact, for papers by Dushyant Verma Breakdown of academic impact, for papers by Ravin J. Garg Breakdown of academic impact, for papers by R. Hehlmann Breakdown of academic impact, for papers by Kaddour Chabane
Rankless by CCL
2026